Effect of intravenous administration of dextrose on coagulation in healthy dogs

American Journal of Veterinary Research

Volumn 72, Issue 4, 2011, Pages 562-569

  Gonzales, Jennifer L ^a   Hanel, Rita M ^a   Hansen, Bernie D ^a   Marks, Steve L ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; GLUCOSE; INFUSION FLUID;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CRYSTALLOID; DOG; ENERGY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MALE; NONHUMAN; NUTRITION; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; SAMPLING; THROMBOELASTOGRAPHY; ANIMAL; CHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; PHYSIOLOGY;

ANIMALIA; CANIS FAMILIARIS;

ANIMALS; BLOOD COAGULATION; DOGS; GLUCOSE; HYPERGLYCEMIA; INFUSIONS, INTRAVENOUS; MALE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME;

EID: 79955537582     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.72.4.562     Document Type: Article

References (51)

1. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003;78:1471-1478.
2. Inzucchi SE. Management of hyperglycemia in the hospital setting. N Engl J Med 2006;355:1903-1911.
3. Lazzeri C, Tarquini R, Giunta F, et al. Glucose dysmetabolism and prognosis in critical illness. Intern Emerg Med 2009;4:147-156.
4. Dhindsa S, Tripathy D, Mohanty P, et al. Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-κB in mononuclear cells. Metabolism 2004;53:330-334.
5. Mohanty P, Hamouda W, Garg R, et al. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000;85:2970-2973.
6. King GL, Loeken MR. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 2004;122:333-338.
7. Yu WK, Li WQ, Li N, et al. Infuence of acute hyperglycemia in human sepsis on infammatory cytokine and counterregulatory hormone concentrations. World J Gastroenterol 2003;9:1824-1827.
8. Esposito K, Nappo F, Marfella R, et al. Infammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002;106:2067-2072.
9. Stegenga ME, van der Crabben SN, Levi M, et al. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fbri-nolysis in healthy humans. Diabetes 2006;55:1807-1812.
10. Rao AK, Chouhan V, Chen X, et al. Activation of the tissue factor pathway of blood coagulation during prolonged hyperglyce-mia in young healthy men. Diabetes 1999;48:1156-1161.
11. Pandolf A, Giaccari A, Cilli C, et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fbrinolytic activity and increase plasminogen activator inhibitor type I in the rat. Acta Diabetol 2001;38:71-76.
12. Chandler WL. The thromboelastography and the thromboelas-tograph technique. Semin Thromb Hemost 1995;21(suppl 4):1-6.
13. Stegenga ME, van der Crabben SN, Blumer RM, et al. Hypergly-cemia enhances coagulation and reduces neutrophil degranula-tion, whereas hyperinsulinemia inhibits fbrinolysis during human endotoxemia. Blood 2008;112:82-89.
14. Vaidyula VR, Rao AK, Mozzoli M, et al. Effects of hyper-glycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. Diabetes 2006;55:202-208.
15. Sakamoto T, Ogawa H, Kawano H, et al. Rapid change of platelet aggregability in acute hyperglycemia. Thromb Haemost 2000;83:475-479.
16. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-1367.
17. van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-461.
18. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1297.
19. Finney SJ, Zekveld C, Elia A, et al. Glucose control and mortality in critically ill patients. JAMA 2003;290:2041-2047.
20. Torre DM, deLaforcade AM, Chan DL. Incidence and clinical relevance of hyperglycemia in critically ill dogs. J Vet Intern Med 2007;21:971-975.
21. Brady CA, Hughes D, Drobatz KJ. Association of hyponatremia and hyperglycemia with outcome in dogs with congestive heart failure. J Vet Emerg Crit Care 2004;14:177-182.
22. Pyle SC, Marks SL, Kass PH. Evaluation of complications and prognostic factors associated with administration of total paren-teral nutrition in cats: 75 cases (1994-2001). J Am Vet Med Assoc 2004;225:242-250.
23. Millis DL, Hawkins E, Jager M, et al. Comparison of coagulation test results for blood samples obtained by means of direct venipuncture and through a jugular vein catheter in clinically normal dogs. J Am Vet Med Assoc 1995;207:1311-1314.
24. Sinnott VB, Otto CM. Use of thromboelastography in dogs with immune-mediated hemolytic anemia: 39 cases (2000-2008). J Vet Emerg Crit Care 2009;19:484-488.
25. Otto CM, Rieser TM, Brooks MB, et al. Evidence of hyperco-agulability in dogs with parvoviral enteritis. J Am Vet Med Assoc 2000;217:1500-1504.
26. Kristensen AT, Wiinberg B, Jessen LR, et al. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med 2008;22:140-147.
27. Wiinberg B, Jensen AL, Johansson PI, et al. Thromboelasto-graphic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 2008;22:357-365.
28. McCrath DJ, Cerboni E, Frumento RJ, et al. Thromboelastog-raphy maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005;100:1576-1583.
29. Wiinberg B, Jensen AL, Rojkjaer R, et al. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Vet Clin Pathol 2005;34:389-393.
30. Dai Y, Lee A, Critchley LA, et al. Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature. Anesth Analg 2009;108:734-742.
31. Welsby IJ, Jiao K, Ortel TL, et al. The kaolin-activated thrombo-elastograph predicts bleeding after cardiac surgery. J Cardiotho-rac Vasc Anesth 2006;20:531-535.
32. Bauer N, Eralp O, Moritz A. Establishment of reference intervals for kaolin-activated thromboelastography in dogs including an assessment of the effects of sex and anticoagulant use. J Vet Di-agn Invest 2009;21:641-648.
33. Wiinberg B, Jensen AL, Rozanski E, et al. Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs. Vet J 2009;179:121-129.
34. Stokol T. Plasma D-dimer for the diagnosis of thromboem-bolic disorders in dogs. Vet Clin North Am Small Anim Pract 2003;33:1419-1435.
35. Cheng T, Mathews KA, Abrams-Ogg ACG. Relationship between assays of infammation and coagulation: a novel interpretation of the canine activated clotting time. Can J Vet Res 2009;73:97-102.
36. Schafer AI. Thrombocytosis. N Engl J Med 2004;350:1211-1219.
37. Devaraj S, Venugopal SK, Singh U, et al. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein ki-nase c-{alpha} and -{beta}. Diabetes 2005;54:85-91.
38. Morohoshi M, Fujisawa K, Uchimura I, et al. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 1996;45:954-959.
39. Zentek J, Stephan I, Kramer S, et al. Response of dogs to short-term infusions of carbohydrate- or lipid-based parenteral nutrition. J Vet Med A Physiol Pathol Clin Med 2003;50:313-321.
40. Wolfe RR, O'Donnell TF Jr, Stone MD, et al. Investigation of factors determining the optimal glucose infusion rate in total parenteral nutrition. Metabolism 1980;29:892-900.
41. Rosmarin DK, Wardlaw GM, Mirtallo J. Hyperglycemia associated with high continuous infusion rates of total parenteral nutrition dextrose. Nutr Clin Pract 1996;11:151-156.
42. Michael SR, Sabo CE. Management of the diabetic patient receiving nutritional support. Nutr Clin Pract 1989;4:179-183.
43. Vaidyula AR, Boden G, Rao AK. Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects. Platelets 2006;17:577-585.
44. Ruttman TG, James M F, Wells K F. Effect of 20% in vitro haemo-dilution with warmed buffered salt solution and cerebrospinal fuid on coagulation. Br J Anaesth 1999;82:110-111.
45. Roche AM, James M F, Bennet-Guerrero E, et al. A head-to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystalloid and colloid intravenous fu-ids. Anesth Analg 2006;102:1274-1279.
46. Ng KFJ, Lam CCK, Chan LC. In vivo effect of haemodilution with saline on coagulation: a randomized controlled trial. Br J Anaesth 2002;88:475-480.
47. Wagman LD, Newsome HH, Miller KB. The effect of acute discontinuation of total parenteral nutrition. Ann Surg 1986;204:524-529.
48. Krzywda EA, Andris DA, Whipple JK, et al. Glucose response to abrupt initiation and discontinuation of total parenteral nutrition. J Parent Enteral Nutr 1993;17:64-67.
49. Bendorf K, Friesen CA, Roberts CC. Glucose response to discontinuation of parenteral nutrition in patients less than 3 years of age. J Parenter Enteral Nutr 1996;20:120-122.
50. Sharma SK, Philip J, Wiley J. Thromboelastographic changes in healthy parturients and postpartum women. Anesth Analg 1997;85:94-98.
51. Francis JL, Francis DA, Gunathilagan GJ. Assessment of hyper-coagulability in patients with cancer using the Sonoclot analyzer and thromboelastography. Thromb Res 1994;74:335-346.